PCSK9 and familial hypercholesterolemia: Thus, PCSK9 monoclonal antibody or siRNA therapy that is currently used in clinics worldwide to treat hypercholesterolemia could be useful to study as a combined therapeutic strategy for cancer/metastasis [51].